Evaluation of cardiotoxicity and other adverse effects associated with concomitant administration of artemether/lumefantrine and atazanavir/ritonavir-based antiretroviral regimen in patients living with HIV
2022Saudi Pharmaceutical JournalJournalOpen access
10.1016/j.jsps.2022.02.010Full text2 citations